humanitarian Archived signal

Human medicines European public assessment report (EPAR): Beromun, tasonermin, Date of authorisation: 12/04/1999, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reported by EMA What Is New Oct 19, 2026 · 12:44 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Beromun, tasonermin, Date of authorisation: 12/04/1999, Revision: 16, Status: Authorised12:44 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Beromun, tasonermin, Date of authorisation: 12/04/1999, Revision: 16, Status: Authorised12:44 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Vizimpro, dacomitinib, Date of authorisation: 02/04/2019, Revision: 4, Status: Authorised12:43 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Vizimpro, dacomitinib, Date of authorisation: 02/04/2019, Revision: 4, Status: Authorised12:43 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Iressa, gefitinib, Date of authorisation: 24/06/2009, Revision: 16, Status: Authorised12:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Iressa, gefitinib, Date of authorisation: 24/06/2009, Revision: 16, Status: Authorised12:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Yesafili, aflibercept, Date of authorisation: 15/09/2023, Revision: 9, Status: Authorised11:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Yesafili, aflibercept, Date of authorisation: 15/09/2023, Revision: 9, Status: Authorised11:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Vgenfli, aflibercept, Date of authorisation: 14/08/2025, Revision: 1, Status: Authorised11:40 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Vgenfli, aflibercept, Date of authorisation: 14/08/2025, Revision: 1, Status: Authorised11:40 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 3, Status: Authorised11:38 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 3, Status: Authorised11:38 UTC

INCIDENT EVOLUTION

1 recorded state

Oct 19 · 13:02 UTC

Signal first indexedP2 · 99% quality · 2 sources

Explore this day in the archive →